upcoming glp 1 drugs 9 Companies Developing Next-Generation GLP-1 GLP-1 Medications Infographic | Medidex

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

The current KDIGO guidelines do not recommend SGLT2i for people in more advanced stages of CKD (eGFR 300 mg/g) and reduced progression of UACR in people with macroalbuminuria when compared with placebo

What it does not show: efficacy in chronic tendinopathy, in non-rodent species under controlled conditions, in humans, or under sham-injection-controlled and pre-registered protocols

A proof-of-concept trial investigating metformin as an add-on treatment for mild or moderate SLE demonstrated that metformin down-regulated the NETs mtDNA-PDC-IFN pathway, leading to clinical improvement of SLE and reduced its reliance on prednisolone (133)

Amylin is co-secreted with insulin from pancreatic beta cells in response to meals, functioning as a complementary satiety signal that operates through distinct receptors and mechanisms from insulin and GLP-1

List prices top $1,000 a month, though both offer cash buyers a $499 monthly supply